Clinical Trial Update: Neurotropin to Treat Chronic Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 trial of Neurotropin for complex regional pain syndrome was terminated. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome Type
• Complex Regional Pain Syndrome Type Ii

Drugs mentioned

• Neurotropin

Snippet

Sponsor: National Institute of Nursing Research (NINR) | Conditions: Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome Type II | Phase 2 | Status: TERMINATED | Results posted: 2016-06-21